A propitious time for initiating clinical trials in patients with heart failure with reduced ejection fraction and an estimated glomerular filtration rate <30 mL/min with an mineralocorticoid receptor antagonist and a K+binder: ‘the forbidden fruit’
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.